Navigation Links
Pergamum to Provide Effective Development of Innovative Dermatology and Wound Healing Companies
Date:9/10/2009

STOCKHOLM, September 10 /PRNewswire/ -- Pergamum AB has announced its formation; Pergamum will commercialize the Karolinska Development dermatology and wound healing interests, and create a broad-based therapeutic company in its focus areas.

The Pergamum product pipeline consists of five development projects, three of which are undergoing clinical trials. Indications covered within the portfolio include improved wound healing and reduced scar formation, healing hard-to-heal-wounds, the prevention of bacterial and fungal infections, atopic dermatitis and infected wounds and burns.

Pergamum CEO Magnus Precht will present Pergamum at the Rodman & Renshaw Annual Global Investment Conference in New York September 9-11, 2009 and will be available for one-on-one meetings with investors and potential partners during the conference.

"Pergamum represents a unique approach to developing new biopharmaceuticals in the dermatology and wound care markets," said Magnus Precht, CEO of Pergamum AB. "The fact that the group is working within related fields means we are able to build capabilities and specialist knowledge tailored to the needs of the group. We will provide individual projects with access to technical skills and key competencies without creating bureaucratic layers. This should translate into improved quality, cost savings and, ultimately, a shorter path to regulatory approval. It also means we have a broader, more attractive offering when meeting with pharma companies to discuss eventual sales or licensing opportunities," added Mr Precht.

Pergamum's current projects include: wound healing (Omnio Healer), atopic dermatitis / anti-inflamatory (BioCis Pharma), atopic dermatitis / anti-infective (DermaGen), anti-adhesion / wound healing (PharmaSurgics), and wound healing for chronic wounds (Lipopeptide). Karolinska Development owns 64% of Pergamum, with the other owners being Oste
'/>"/>

SOURCE Karolinska Development AB
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. PharmaNet Development Group Provides Financial Update and Announces Geographic Expansion
2. Hyland Software Provides Grant Assistance to Kick-Start Technology Projects
3. PDL BioPharma Provides Third Quarter 2009 Revenue Guidance of Approximately $71 Million
4. ValGenesis, Inc., the Leading Provider of Validation Lifecycle Management Solutions to Regulated Life Science Companies, Today Announced Support for EMC Documentum v.6.5
5. ChemBridge Corporation and Collaborative Drug Discovery Announce Strategic Collaboration to Provide Diverse Chemical Libraries Together With Researchers Own Private Data
6. Ambry Genetics Announces Certified Service Provider Status for Agilent Microarrays
7. Leading European Contract Research Organization Selects OmniComm to Provide eClinical Solutions for Important Phase III Study
8. Wyeth Provides Regulatory Update on Prevnar 13* in the United States
9. Sigma-Aldrich Acquires ChemNavigator, Inc., to Provide Researchers With Industry-Leading Chemical Compound Selection and Procurement Services
10. ThermoGenesis Provides Update on Fiscal 2009 Results
11. GeoVax Labs, Inc. Provides Clinical Studies Update

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...A, Md., Nov. 19 Spherix ...technology for diabetes therapy, and a provider of...ood, supplement, biotechnology and pharmaceutical ...y reported $6.3 million registered direct placemen...f its common stock and warrants to purchase up to ...
(Date:11/19/2009)...PRNewswire/ - Aegera Therapeutics Inc. announced t...ed Phase 2B study of AEG35156, a targeted antisens...e oncology indications. ,, The study, entitled ...inked Inhibitor of Apoptosis (XIAP) Antisense AEG3...e and Idarubicin in AML Following Failure of a Sin...
(Date:11/18/2009)...18 Marrone Bio Innovations (MBI), ...ialization of effective and environmentally respon...has been named an IC20 company by the Investors, C...nal angel investing group. ,, Companies named t...ng results for all stakeholders, including investo...
(Date:11/18/2009)...Nov. 18 Sangamo BioScien...ta from the University of Pennsylvania investigato... finger nuclease (ZFN) based product, SB-728-T, fo...losed on the internet. ,, Data were presented i...ia School of Medicine from a single subject treate...
Breaking Biology Technology:Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2Marrone Bio Innovations Named an IC20 Company 2Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB-728-T for HIV/AIDS 2
..., Calif., Dec. 16 Neurobiological,Technologies, I...t Celtic,Pharmaceutical Holdings L.P. (Celtic) has...ld the worldwide rights and assets related to XERE...o receive milestone payments upon the,achievement ...s approved for,commercial sale, NTI is also entitl...
...Mass.Dec. 16 NxStage Medical, Inc. (Nasdaq: NXT... products, today announced that Jeffrey H. Burbank...Financial Officer, will be presenting at the JPMor..., 2009 at the Westin St. Francis Hotel in San Fran... scheduled for Wednesday, January 14th at 4:30 p.m...
... Forum Attendees to Keep up Fight, Restore U.S.,s ...lvania,s commitment to developing and diversifying...o weather the economic downturn and set the stage ...ward G. Rendell said today. , , "In Pennsylva...ovation economy, and we are working hard to take a...
Other Biology Technology:Neurobiological Technologies' Partner, Celtic Pharma, Provides Update on XERECEPT(R) Clinical Program and Planned Sale in 2009 2Neurobiological Technologies' Partner, Celtic Pharma, Provides Update on XERECEPT(R) Clinical Program and Planned Sale in 2009 3Neurobiological Technologies' Partner, Celtic Pharma, Provides Update on XERECEPT(R) Clinical Program and Planned Sale in 2009 4NxStage to Present at the JPMorgan Healthcare Conference 2Governor Rendell Says Life Science Industry Will Fuel New Breakthroughs, Generate Jobs for Decades to Come 2Governor Rendell Says Life Science Industry Will Fuel New Breakthroughs, Generate Jobs for Decades to Come 3
(Date:11/20/2009)...2009) Scientists from the Marine Biogeochemistry ...esearch Laboratory (NRL) organized and led a team ...ic expedition to initiate methane hydrate explorat...variation of sediment contribution to Arctic clima...er Polar Sea as a research platform, three cross-s...
(Date:11/20/2009)...ingle bacterial gene into yeast, researchers from ...achieved three improvements in bioethanol producti..., less acetate and elimination of the major by-pro...ed in the scientific journal Applied and Environm... is made by the yeast Saccharomyces cerevisiae fro...
(Date:11/20/2009)...y disease (COPD), a respiratory disease commonly k...urth leading cause of death worldwide. 600 millio... yet to find any real treatment or cure, Grace Par...ty of Western Ontario in London, Canada, is using ...o the disease. , Parraga is a scientist in t...
Breaking Biology News(10 mins):International expedition investigates climate change, alternative fuels in Arctic 2Delft breakthrough in bioethanol production from agricultural waste 2Gaining a better picture of lung disease 2Network Merchants Inc 28NMI 29 Founders Donate 2450 000 to Schaumburgs Childrens Home 26 Aid 47692 1Network Merchants Inc 28NMI 29 Founders Donate 2450 000 to Schaumburgs Childrens Home 26 Aid 47692 2MedSolutions 3A Accurate Diagnosis Is Critical to Reducing Healthcare Costs 47688 1MedSolutions 3A Accurate Diagnosis Is Critical to Reducing Healthcare Costs 47688 2MedSolutions 3A Accurate Diagnosis Is Critical to Reducing Healthcare Costs 47688 3MedSolutions 3A Accurate Diagnosis Is Critical to Reducing Healthcare Costs 47688 417 Million U S Children Live More Than an Hour Away From Trauma Care 47684 117 Million U S Children Live More Than an Hour Away From Trauma Care 47684 217 Million U S Children Live More Than an Hour Away From Trauma Care 47684 3
...cials around the world keep a nervous eye on the s...chewan,s Vaccine and Infectious Disease Organizati...uenza virus causes infection. , Yan Zhou and her t...ports the influenza A virus,s ability to reproduce...e way for new drugs and vaccines. , The paper ...
...ing at Cornell University in Ithaca and Weill Corn...ed a panel of 23 protein biomarkers in cerebrospin...," which doctors might use someday to identify pat...rch will be published in the December online-editi...now, physicians rely on their clinical judgment to...
...n bacteria in the Earth, Shewanella oneidensis MR-.... But in the absence of oxygen, Shewanella uses (o...lso have adsorbed heavy metals on them. As a resul...bility of iron and environmental contaminants like...yaditya Bose and Professor Michael Hochella Jr., b...
Other Biology News:U of S Vaccine and Infectious Disease Organization team discovers key step in flu virus replication 2Protein 'fingerprint' in spinal fluid could spot Alzheimer's disease 2Protein 'fingerprint' in spinal fluid could spot Alzheimer's disease 3Particle size matters to bacteria ability to immobilize heavy metals 2Particle size matters to bacteria ability to immobilize heavy metals 3
...denses and traps a wide variety of solvent vapors ...Easy-to-use glass condensation flask (GCF400) allo...ned jar for easy draining. Rapid cooling time mini...ask for quick solvent changes , -50?C Temeratu...
Lambda Protein Phosphatase from New England Biolabs
Shrimp Phosphatase, Alkaline, Unconjugated from Sigma-Aldrich
...high performance spectral scanning multimode reade...advanced SkanIt Software it offers superior flexib...elopment. Varioskan provides unlimited wavelength ...d fluorescence and photometric assays and a dispen...
Biology Products: